MoneyWorks4Me

Kimia Biosciences informs about statement of investor complaints/grievances

22 Jan 2025 Evaluate
Pursuant to Regulation 13(3) of the SEBI (Listing and Obligation and Disclosures requirements) Regulation2015, Kimia Biosciences has informed that it enclosed the statement of investor complaints/grievances for the quarter ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..